CVE-2014-5406 : 상세 정보

CVE-2014-5406

0.55%V4
2015-07-06
19h10 +00:00
A08-Soft and Data Integrity Fail
Network
2025-11-03
18h34 +00:00
특정 CVE 알림
특정 CVE의 변경 사항에 대한 정보를 받아보세요.
알림 관리

CVE 설명

Hospira LifeCare PCA Infusion System

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

CVE 해결 방법

ICS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002.

CVE 정보

관련 약점

CWE-ID 약점 이름 출처
CWE-345 Insufficient Verification of Data Authenticity
The product does not sufficiently verify the origin or authenticity of data, in a way that causes it to accept invalid data.

메트릭

메트릭 점수 심각도 CVSS 벡터 출처
V2 7.6 AV:N/AC:H/Au:N/C:C/I:C/A:C
V2 9.3 AV:N/AC:M/Au:N/C:C/I:C/A:C nvd@nist.gov

EPSS

EPSS는 취약점이 악용될 가능성을 예측하는 점수 모델입니다.

EPSS 점수

EPSS 모델은 0과 1(0~100%) 사이의 확률 점수를 생성합니다. 점수가 높을수록 취약점이 악용될 가능성이 높습니다.

EPSS 백분위수

백분위수는 EPSS 점수에 따라 CVE의 순위를 매기는 데 사용됩니다. 예를 들어 EPSS 점수 기준 95번째 백분위수의 CVE는 다른 CVE의 95%보다 악용될 가능성이 높습니다.

언급된 제품

구성 0

Hospira>>Lifecare_pcainfusion_firmware >> Version 까지 (포함) 5.0

Hospira>>Lifecare_pca3 >> Version -

Hospira>>Lifecare_pca5 >> Version -

참고 자료

https://ics-cert.us-cert.gov/advisories/ICSA-15-125-01
Tags : Third Party Advisory, US Government Resource